[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance, Complicated Intra-Abdominal Infections: Developing Drugs for Treatment.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Acute Bacterial Exacerbations of Chronic Bronchitis in Patients With Chronic Obs...[ Price : $8.95]
Federal Register Notice: CDER plans a public workshop 2/11-12/13 to discuss clinical development of disease-modifying agents for t...[ Price : $8.95]
Coyote Pharmaceuticals plans to file an IND with FDA and begin a clinical program in 2013 for its CNS-102 to treat Amyotrophic Lat...[ Price : $8.95]
PhRMA adopts new principles to guide interactions between pharmaceutical companies and patient organizations in the wake of the ne...[ Price : $8.95]
FDA releases a draft guidance for industry to assist sponsors in developing drugs for treating complicated intra-abdominal infecti...[ Price : $8.95]
Federal Register Notice: Due to scheduling issues, FDA postpones a 10/15 Gastrointestinal Drugs Advisory Committee slated to discu...[ Price : $8.95]
PhRMA files an amicus brief asking the Supreme Court to resolve whether brand and generic companies can reach monetary settlements...